Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Active-controlled, Parallel Group, Stratified, Multi-center, 12-Week Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™ 250/10ug Twice Daily) in a Single Inhaler (SkyePharma HFA pMDI) With the Administration of Fluticasone (250ug Twice Daily) Alone in SkyePharma HFA pMDI and Flovent® HFA pMDI in Adolescent and Adult Patients With Moderate to Severe Asthma
Brief Summary: The medications being used in this study are individually approved by the Food and Drug Administration (FDA). The medication under investigation is a combination of two medications in one inhaler. The purpose of this study is to determine how well your asthma is controlled when taking one of the three treatment.


Options:
A: Arm Label: Fluticasone Furoate/Vilanterol 100/25 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler, Drug: Placebo inhalation powder via ACCUHALER/DISKUS inhaler | Arm Label: Fluticasone Propionate/Salmeterol 250/50 mcg; Type: EXPERIMENTAL; Interventions: Drug: Placebo inhalation powders via ELLIPTA inhaler, Drug: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler | Arm Label: Fluticasone Propionate 250 mcg; Type: EXPERIMENTAL; Interventions: Drug: Placebo inhalation powders via ELLIPTA inhaler, Drug: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler | Intervention Type: DRUG; Name: Fluticasone Furoate/Vilanterol 100/25 mcg via ELLIPTA inhaler; Assigned to Arm(s): Fluticasone Furoate/Vilanterol 100/25 mcg | Intervention Type: DRUG; Name: Placebo inhalation powders via ELLIPTA inhaler; Assigned to Arm(s): Fluticasone Propionate 250 mcg, Fluticasone Propionate/Salmeterol 250/50 mcg | Intervention Type: DRUG; Name: Fluticasone Propionate/Salmeterol 250/50 mcg via ACCUHALER/DISKUS inhaler; Assigned to Arm(s): Fluticasone Propionate/Salmeterol 250/50 mcg | Intervention Type: DRUG; Name: Placebo inhalation powder via ACCUHALER/DISKUS inhaler; Assigned to Arm(s): Fluticasone Furoate/Vilanterol 100/25 mcg | Intervention Type: DRUG; Name: Fluticasone Propionate 250 mcg via ACCUHALER/DISKUS inhaler; Assigned to Arm(s): Fluticasone Propionate 250 mcg
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: FlutiForm 250/10 | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: SKP-Fluticasone | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Flovent Fluticasone HFA | Intervention Type: DRUG; Name: FlutiForm 250/10; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: SKP-Fluticasone; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Flovent Fluticasone HFA; Assigned to Arm(s): 3
C: Arm Label: tiotropium 5mcg/day; Type: EXPERIMENTAL; Interventions: Drug: tiotropium 5mcg/day | Arm Label: placebo; Type: EXPERIMENTAL; Interventions: Drug: placebo | Intervention Type: DRUG; Name: tiotropium 5mcg/day; Assigned to Arm(s): tiotropium 5mcg/day | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
D: Arm Label: Fp MDPI 100 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol HFA | Arm Label: FLOVENT HFA 110 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT HFA, Drug: albuterol/salbutamol HFA | Arm Label: Fp MDPI 200 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol HFA | Arm Label: FLOVENT HFA 220 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT HFA, Drug: albuterol/salbutamol HFA | Arm Label: FS MDPI 100/12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: albuterol/salbutamol HFA | Arm Label: ADVAIR DISKUS 250/50 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: ADVAIR DISKUS, Drug: albuterol/salbutamol HFA | Arm Label: FS MDPI 200/12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: albuterol/salbutamol HFA | Arm Label: ADVAIR DISKUS 500/50 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: ADVAIR DISKUS, Drug: albuterol/salbutamol HFA | Intervention Type: DRUG; Name: Fp MDPI; Assigned to Arm(s): Fp MDPI 100 mcg, Fp MDPI 200 mcg | Intervention Type: DRUG; Name: FS MDPI; Assigned to Arm(s): FS MDPI 100/12.5 mcg, FS MDPI 200/12.5 mcg | Intervention Type: DRUG; Name: FLOVENT HFA; Assigned to Arm(s): FLOVENT HFA 110 mcg, FLOVENT HFA 220 mcg | Intervention Type: DRUG; Name: ADVAIR DISKUS; Assigned to Arm(s): ADVAIR DISKUS 250/50 mcg, ADVAIR DISKUS 500/50 mcg | Intervention Type: DRUG; Name: albuterol/salbutamol HFA; Assigned to Arm(s): ADVAIR DISKUS 250/50 mcg, ADVAIR DISKUS 500/50 mcg, FLOVENT HFA 110 mcg, FLOVENT HFA 220 mcg, FS MDPI 100/12.5 mcg, FS MDPI 200/12.5 mcg, Fp MDPI 100 mcg, Fp MDPI 200 mcg

Answer: B